Losartan Potassium Tablet, Film Coated
Product Images NDC 55154-2333
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 55154-2333). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Losapotatab2 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 02)
The text provided is related to a medical study that compares the efficacy of two drugs Atenolol and Losartan Potassium in reducing the risk of the primary endpoint. The study reports an adjusted risk reduction of 13% with a p-value of 0.021. However, since there is no information about the primary endpoint, it is difficult to determine the clinical significance of the findings. The text also includes a chart that shows the study month and the number of patients at each time point.*
Losapotatab3 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 03)
This appears to be a chart or table showing the percentage of patients who experienced a fatal or non-fatal stroke while taking either Atenolol or Losartan Potassium. It also includes an "adjusted risk reduction" of 25% with a p-value of 0.001. However, without additional information or context, it is difficult to provide a more detailed description or interpretation of this data.*
Losapotatab (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 04)
Losapotatab5 (C516a5a7 Cfc8 4b3b A8bc 7644c3313673 05)
F3b67cfc 83f1 4210 Bf84 D337ce067349 00
Losartan Potassium Tablets are a prescription medication used for treating high blood pressure. Each tablet contains 100 g of Losartan Potassium. The recommended dosage and other important information are listed in the product insert. The tablets should be stored at room temperature and protected from light. This particular package is not child-resistant and is intended for institutional use only. The manufacturer is Cadia Healthcare Ltd in India, while the distributors are 2yaus Pharmaceuticals (USA) Inc and Major Pharmaceuticals.*
F3b67cfc 83f1 4210 Bf84 D337ce067349 01
Losartan Potassium Tablets is a medication manufactured by Cadila Healthcare Ltd in India and distributed by Major Pharmaceuticals, which contains 50mg of losartan potassium, USP. It comes in a package that contains 10 tablets with an NDC (National Drug Code) number of 55154-2327-0. To get the usual dosage, consult the product insert for complete prescribing information, precautions, and warnings. The medication should be stored at 20° to 25°C (68" to 77°F) in a tight light-resistant container and protected from light. The unit dose package is not child-resistant and intended for institutional use only. It is RX ONLY and dispensed by pharmacists with patient information sheets.*
F3b67cfc 83f1 4210 Bf84 D337ce067349 02
Losartan Potassium is a medication that comes in a package of 10 tablets, with each tablet containing 25 mg of Losartan Potassium. It is advised to read the enclosed product insert for complete prescribing information, precautions, and warnings. The medication should be stored at a controlled temperature range of 20° to 25°C and protected from light. The package is not suitable for child-resistant storage and should, therefore, be kept out of the reach of children. The product is manufactured in India by Cadila Healthcare Ltd and distributed in the USA by Zydus Pharmaceuticals and Major Pharmaceuticals.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.